Transformation by human papillomavirus 16 E6 and E7: Role of the insulin-like growth factor 1 receptor

Cancer Research

Volumn 56, Issue 21, 1996, Pages 5087-5091

  Steller, Michael A ^a   Zou, Zhiqiang ^a   Schiller, John T ^a   Baserga, Renato ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C RECEPTOR; STAUROSPORINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; GENE DISRUPTION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; RECEPTOR BINDING; TUMOR SUPPRESSOR GENE; VIRUS TRANSFORMATION;

EID: 0029950310     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p33 mutations in human cancers Science (Washington DC), 253: 49-53, 1991.
2. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes Nature (Lond.), 362: 847-849, 1993.
3. Lechner, M. S., and Laimins, L. A. Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J. Virol., 68: 4262-4273, 1994.
4. 1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA, 91: 5320-5324, 1994.
5. Baserga, R. Oncogenes and the strategy of growth factors. Cell, 79: 927-930, 1994.
6. Kaleko, M., Rutter, W. J., and Miller, A. D. Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation Mol. Cell Biol., 10: 464-473, 1990.
7. Prager, D., Li, H. L., Asa, S., and Melmed, S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant Proc. Natl. Acad. Sci. USA, 91: 2181-2185, 1994.
8. Drummond, I. A., Madden, S. L., Rohwer-Nutter, P., Bell, G. I., Sukhatme, V. P., and Rauscher, F. J. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1 Science (Washington DC), 257: 674-678, 1992.
9. Christofori, G., Naik, P., and Hanahan, D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature (Lond.), 369: 414-418, 1994.
10. Sell, C., Baserga, R., and Rubin, R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res., 55: 303-306, 1995.
11. Sell, C., Rubini, M., Rubin, R., Liu, J. P., Efstratiadis, A., and Baserga, R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA, 90: 11217-11221, 1993.
12. Bertrand, R., Solary, E., O'Connor, P., Kohn, K. W., and Pommier, Y. Induction of a common pathway of apoptosis by staurosporine Exp Cell Res., 211: 314-321, 1994.
13. Meikrantz, W., Gisselbrecht, S., Tam, S. W., and Schlegel, R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc. Natl. Acad. Sci. USA, 91: 3754-3758, 1994.
14. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 923-935, 1992.
15. Sedman, S. A., Barbosa, M. S., Vass, W. C., Hubbert, N. L., Haas, J. A., Lowy, D. R., and Schiller, J. T. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J. Virol., 65: 4860-4866, 1991.
16. Lammers, R., Van Obberghen, E., Ballotti, R., Schlessinger, J., and Ullrich, A. Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor actuation. J. Biol. Chem., 265: 16886-16890, 1990.
17. Kato, H., Faria, T. N., Stannard, B., Roberts, C. T., Jr., and LeRoith, D. Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (α IR-3) J. Biol. Chem., 268: 2655-2661, 1993.
18. Sumantran, V. N., Ealovega, M. W., Nunez, G., Clarke, M. F., and Wicha, M. S. Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res., 55: 2507-2510, 1995.
19. Del Bino, G., Skierski, J. S., and Darzynkiewicz, Z. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Exp. Cell Res., 195: 485-491, 1991.
20. Peterson, E. P., Martinez, G. M., Martinez-Zaguilan, R., Perona, R., and Gillies, R. J. NIH 3T3 cells transfected with a yeast H(+)-ATPase have altered sensitivity to insulin, insulin growth factor-I, and platelet-derived growth factor-AA. J. Cell Physiol., 159: 551-560, 1994.
21. White, E. Tumour biology p53, guardian of Rb. Nature (Lond.), 371: 21-22, 1994.
22. Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., and Baserga, R. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell Biol., 14: 3604-3612, 1994.
23. Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-I) and type 1 IGF receptor (Igf1r) Cell, 75: 59-72, 1993.
24. Baker, J., Liu, J. P., Robertson, E. J., and Efstratiadis. A Role of insulin-like growth factors in embryonic and postnatal growth. Cell, 75: 73-82, 1993.
25. Barres, B. A., Hart, I. K., Coles, H. S., Burne, J. F., Voyvodic, J. T., Richardson, W. D., and Raff, M. C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell, 70: 31-46, 1992.
26. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H. L., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
27. Resnicoff, M., Sell, C., Rubini, M., Coppola, D., Ambrose, D., Baserga, R., and Rubin, R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-I (IGF-I) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res., 54: 2218-2222, 1994.
28. McCubrey, J. A., Steelman, L. S., Mayo, M. W., Algate, P. A., Dellow, R. A., and Kaleko, M. Growth-promoting effects of insulin-like growth factor-I (IGF-I) on hematopoietic cells: overexpression of introduced IGF-I receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism. Blood, 78: 921-929, 1991.
29. Miura, M., Li, S., and Baserga, R. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells Cancer Res., 55: 663-667, 1995.
30. Steller, M. A. Delgado, C. H., Battels, C. J., Woodworth, C. D., and Zou, Z. Overexpression of the insulin-like growth factor-I receptor and autocrine stimulation in human cervical cancer cells. Cancer Res., 56: 1761-1765, 1996.
31. Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., and Shah, K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group [see comments]. J. Natl. Cancer Inst., 87: 796-802, 1995.
32. Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., and zur Hausen, H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (Lond.), 314: 111-114, 1985.
33. Morrione, A., DeAngelis, T., and Baserga, R. Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes. J. Virol., 69: 5300-5303, 1995.
34. Nilson, L. A., and DiMaio, D. Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein. Mol. Cell. Biol., 13: 4137-4145, 1993.
35. Petti, L., Nilson, L. A., and DiMaio, D. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein. EMBO J., 10: 845-855, 1991.
36. Stiles, C. D., Capone, G. T., Scher, C. D., Antoniades, H. N., Van Wyk, J. J., and Pledger, W. J. Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc. Natl. Acad. Sci. USA, 76: 1279-1283, 1979.
37. Pledger, W. J., Stiles, C. D., Antoniades, H. N., and Scher, C. D. An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis Proc. Natl. Acad. Sci. USA, 75: 2839-2843, 1978.
38. Rubini, M., Werner, H., Gandini, E., Roberts, C. T., Jr., LeRoith, D., and Baserga, R. Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-I (IGF-I) receptor gene. Exp. Cell Res., 211: 374-379, 1994.
39. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
40. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 Nature (Lond.), 352: 345-347, 1991.
41. Sedman, S. A., Hubbert, N. L., Vass, W. C., Lowy, D. R., and Schiller, J. T. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity J. Virol., 66: 4201-4208, 1992.
42. Chen, J. J., Reid, C. E., Band, V., and Androphy, E. J. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science (Washington DC), 269: 529-531, 1995.
43. Etscheid, B. G., Foster, S. A., and Galloway, D. A. The E6 protein of human papillomavirus type 16 functions as a transcriptional repressor in a mechanism independent of the tumor suppressor protein, p53. Virology, 205: 583-585, 1994.